(Reuters) - Trimel Pharmaceuticals Corp said its experimental sexual disorder drug increased the average number of orgasms in women with an orgasmic disorder in a second mid-stage study. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/BZk85ZJWjEI/story01.htm
Read More
No comments:
Post a Comment